Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2004Endocrine Related CancerOpen Access

Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

View Full Paper
Ask AI
Bookmark
Share

Authors

HJHelen E. JonesUniversity of EdinburghLGLindy GoddardCardiff UniversityJGJulia M.W. GeeAlberta Health Services

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jones et al. (2004) studied this question.

synapsesocial.com/papers/6a760c7e7d7eb453cc70810dhttps://doi.org/10.1677/erc.1.00799
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Type 1 growth factor receptors and their ligands considered as a complex system.2001 · 81 citations
  2. 2Cooperative Regulation of the Invasive and Metastatic Phenotypes by Different Domains of the Type I Insulin-like Growth Factor Receptor β Subunit2001 · 94 citations
  3. 3Regulation of DUI45 human prostate cancer cell proliferation by insulin‐like growth factors and its interaction with the epidermal growth factor autocrine loop1994 · 61 citations
  4. 4Nonendocrine Pathways and Endocrine Resistance2004 · 118 citations